CIENCIASMEDICASNEWS: Fogarty International Center

martes, 30 de enero de 2018

Fogarty International Center

Fogarty International Center

Funding news for global health researchers and partners from Fogarty at NIH

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

Funding Opportunities

Supplemental funding for Fogarty and NIH grantees.

Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) (PA-18-586)
Funds are available for administrative supplements to improve the diversity of the research workforce by recruiting and supporting students, postdoctorates, and eligible investigators from groups that have been shown to be underrepresented in health-related research for some research grants.
Application Receipt/Submission Date(s): Due dates vary

NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations and/or other foreign components may apply.

Pragmatic Trials for Dementia Care in Long-term Services and Support (LTSS) Settings (R61/R33 - Clinical Trial Required) (PAR-18-585)
Application Receipt/Submission Date(s): March 27, 2018; February 20, 2019; and February 20, 2020
The Human BioMolecular Atlas Program (HuBMAP) Integration, Visualization and Engagement (HIVE) Initiative (OT2 Clinical Trials Not Allowed) (RFA-RM-18-001)
Application Receipt Date(s): After acceptance of the corresponding required Letter of Intent (LOI) applications are due April 16, 2018
Development of Cell and Tissue Platforms to Detect Adverse Biological Consequences of Somatic Cell Gene Editing (U01 Clinical Trial Not Allowed) (RFA-RM-18-015)
Application Receipt Date(s): April 3, 2018
Innovative Technologies to Deliver Genome Editing Machinery to Disease-relevant Cells and Tissues (UG3/UH3 Clinical Trial Not Allowed) (RFA-RM-18-016)
Application Receipt Date(s): April 3, 2018
Expanding the Human Genome Editing Repertoire (U01 Clinical Trial Not Allowed) (RFA-RM-18-017)
Application Receipt Date(s): April 3, 2018

NIH clinical trial specific parent announcements.

Successor-in-Interest (Type 6 Parent Clinical Trial Optional) (PA-18-589)
Change of Grantee Organization (Type 7 Parent Clinical Trial Optional) (PA-18-590)
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional) (PA-18-591)
Related blog post: NIH Plans for Issuing Clinical Trial Specific Parent Announcements
NIH OER Extramural Nexus blog, November 8, 2017
More about NIH Parent Announcements for unsolicited or investigator-initiated applications from the NIH Office of Extramural Research

NIH funding opportunities for which United States small business concerns (SBCs) may collaborate with a foreign business entity.

Assistive Technology for Persons with Alzheimer's Disease and Related Dementias and Their Caregivers (R41/R42 - Clinical Trials Optional) (PAR-18-587) and (R43/R44 - Clinical Trial Optional) (PAR-18-588)
Application Receipt/Submission Date(s): April 10, 2018, January 8, 2019, and January 8, 2020